Gambaran Pola Kuman, Resistensi, Faktor Risiko, dan Tingkat Mortalitas pada Pasien Ventilator Associated Pneumonia di General Intensif Care RSUP Hasan Sadikin Bandung

Ezra Oktaliansah, Dhany Budipratama, Rifki Dwi Anugrah Putra

Abstract


Ventilator Associated Pneumonia (VAP) merupakan infeksi paru yang terjadi 48–72 jam setelah tindakan intubasi endotrakeal dan menjadi salah satu infeksi nosokomial paling sering di Intensive Care Unit (ICU), dengan prevalensi mencapai 70-80% dari seluruh kasus pneumonia di rumah sakit. Di Indonesia, insiden VAP tergolong tinggi, terutama disebabkan oleh Acinetobacter baumannii yang bersifat resisten terhadap berbagai antibiotik dan berkontribusi terhadap peningkatan angka mortalitas. Penelitian ini menggunakan metode observasional deskriptif dengan pendekatan retrospektif berdasarkan data rekam medis pasien VAP di ICU RSUP Dr. Hasan Sadikin Bandung periode Januari–Desember 2022. Dari 33 pasien yang diteliti, ditemukan 70 hasil kultur kuman, dengan 55 di antaranya tergolong Multidrug Resistant (MDR). Kuman yang paling dominan adalah Acinetobacter baumannii (85,7% MDR), diikuti Klebsiella pneumoniae (94,4% MDR) dan Pseudomonas aeruginosa (87,5% MDR). Angka mortalitas mencapai 60,6%, dengan tingkat kematian lebih tinggi pada pasien dengan kultur MDR. Faktor risiko yang sering ditemukan ialah hipertensi, penyakit serebrovaskular, dan gagal ginjal kronik. Pola resistensi tinggi teridentifikasi pada Acinetobacter baumannii terhadap cefazolin (95,7%) dan ampicillin-sulbactam (91,3%), Klebsiella pneumoniae terhadap cefazolin (97,0%) dan ceftriaxone (96,8%), serta Pseudomonas aeruginosa terhadap imipenem (94,7%) dan cefazolin (91,7%). Hasil ini menunjukkan perlunya peningkatan program penanganan VAP di RSUP Dr. Hasan Sadikin.


Keywords


General intensive care unit; mortalitas; multidrug-resistant; ventilator-associated pneumonia

Full Text:

PDF

References


  1. Papazian L, Klompas M, Luyt, CE. Ventilator‑associated pneumonia in adults: a narrative review. Intensive Care Med. 2020;46(5):888–906. doi:10.1007/s00134-020-05980-0
  2. Kharel S, Bist A, Mishra SK. Ventilator-associated pneumonia among ICU patients in WHO Southeast Asian region: a systematic review. PLoS One. 2021;16(3):e0247832. doi:10.1371/journal.pone.0247832
  3. Mumtaz H, Saqib M, Khan W, Ismail SM, Sohail H, Muneeb M, dkk. Ventilator associated pneumonia in intensive care unit patients: a systematic review. Ann Med Surg. 2023;85:2932–9. doi:10.1097/MS9.0000000000000836
  4. Santoso P, Sung M, Hartantri Y, Andriyoko B, Sugianli AK, Alisjahbana B, dkk. MDR pathogens as risk factor of mortality in secondary pulmonary bacterial infections among COVID-19 patients: observational studies in two referral hospitals in West Java, Indonesia. Int J Gen Med. 2022;15:4741–51.
  5. Sarda C, Fazal F, Rello J. Management of ventilator-associated pneumonia (VAP) caused by resistant gram-negative bacteria: which is the best strategy to treat?. Expert Rev Respir Med. 2019;13(8):787–98.
  6. Ezeddin M, Nasrul E, Alia E. Prevalensi dan pola sensitivitas antibiotik Acinetobacter baumannii. Maj Kedokter Andalas. 2022;45(1):10–16.
  7. Santajit S, Indrawattana N. Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int. 2016;2016:2475067. doi:10.1155/2016/2475067
  8. Parwati I, Turbawaty DK, Andriyono B, Sugianli AK, Widyatmoko L. Pola mikroba dan kepekaan terhadap berbagai antimikroba RSUP Dr. Hasan Sadikin. Bandung: Departemen Patologi Klinik Fakultas Kedokteran Universitas Padjadjaran; 2017.
  9. Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, dkk. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020;323(15):1478–87.
  10. Mancini S, Verellen LG, Seth-Smith HM, Keller PM, Goldmann NK, Syed MA, dkk. Diagnostic algorithm for the detection of carbapenemases and extended-spectrum β-lactamases in carbapenem-resistant Pseudomonas aeruginosa. Microbiol Spectr. 2025;13(6):e03196–24. doi:10.1128/spectrum.03196-24
  11. Gales AC, Stone G, Sahm DF, Wise MG, Utt E. Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017–2019. J Antimicrob Chemother. 2023;78(7):1606–15. doi:10.1093/jac/dkad127
  12. Alrahmany D, Omar AF, Alreesi A, Harb G, Ghazi IM. Acinetobacter baumannii infection-related mortality in hospitalized patients: risk factors and potential targets for clinical and antimicrobial stewardship interventions. Antibiotics (Basel). 2022;11(8):1–10.
  13. Vivo A, Fitzpatrick MA, Suda KJ, Jones MM, Perencevich EN, Rubin MA, dkk. Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study. BMC Infect Dis. 2022;22(1):1–12.
  14. Du X, Xu X, Yao J, Deng K, Chen S, Shen Z, dkk. Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis. Am J Infect Control. 2019;47(9):1140–5.
  15. Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics (Basel). 2023;12(2):1–12.
  16. Dewi APTT, Mertaniasih NM, Semedi BP, Alimsardjono L, Endraswari PD. Risk factors of ventilator-associated pneumonia in intensive care patients at tertiary referral hospital. Bali Med J. 2023;12(2):1441–5.
  17. Ali HS, Khan FY, George S, Shaikh N, Al-Ajmi J. Epidemiology and outcome of ventilator-associated pneumonia in a heterogeneous ICU population in Qatar. Biomed Res Int. 2016;2016:1–8.
  18. Kalanuria AA, Ziai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care. 2014;18(2):208. doi: 10.1186/cc13775
  19. Grossmann I, Rodriguez K, Soni M, Joshi PK, Patel SC, Shreya D, dkk. Stroke and pneumonia: mechanisms, risk factors, management, and prevention. Cureus. 2021;13(11):e19566. doi:10.7759/cureus.19912
  20. Pant A, Prasai A, Rauniyar AK, Adhikary L, Basnet K, Khadka T. Pneumonia in patients with chronic kidney disease admitted to nephrology department of a tertiary care center: a descriptive cross-sectional study. J Nepal Med Assoc. 2021;59(242):1000–3. doi:10.31729/jnma.7074
  21. Yin M, Liu M. Effect of chronic obstructive pulmonary disease combined with ventilator-associated pneumonia on patient outcomes: a systematic review and meta-analysis. Exp Ther Med. 2020;20(6):273. doi:10.3892/etm.2020.9403




DOI: https://doi.org/10.15851//jap.v13n2.4036

Article Metrics

Abstract view : 0 times
PDF - 0 times



 

This Journal indexed by

                   

           


 
Creative Commons License
JAP is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 



View My Stats